Интерфероны первого типа — индукция и механизмы противовирусного действия

1. Isaacs A., Lindenmann J. Virus interference. I. The interferon. Proc R. Soc Lond B Biol Sci 1957; 147: 258—267

2. Cantell K., Hirvonen S., Kauppinen H. L., Myllyla G. Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods Enzymol. 1981; 78: 29—38

3. Friesen H. J., Stein S., Evinger M. et al. Purification and molecular characterization of human fibroblast interferon. Arch Biochem Biophys 1981; 206: 432—450

4. Rubinstein M., Rubinstein S., Familetty P. C. et al. Human leukocyte interferon purified to homogeneity. Science 1978; 202: 1289—1290.

5. Stein S., Kenny C., Fnesen H. J. et al. NH2-Terminal amino acid sequence of human fibroblast interferon. Proc Natl Acad Sci USA 1980; 77: 5716—5719.

6. Maeda S., McCandliss R., Gross M. et al. Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon. Ibid; 7010—7013.

7. Nagata S., Taira H., Hall A. et al. Synthesis in E.coli of a polypeptide with human leukocyte interferon activity. Nature 1980; 284: 316—320.

8. Goeddel D. V., Yelverton E., Ullrich A. et al. Human leukocyte interferon produced by E.coli is biologically active. Ibid; 287; 411—416.

9. Derynck R., Content J., DeClercq E. Isolation and structure of human fibroblast interferon gene. Ibid; 285: 542—547.

10. Houghton M., Stewart A. G., Doel S. M. et al. The amino-terminal sequence of human fibroblast interferon as deduced from reverse transcripts obtained using synthetic oligonucleotide primers. Nucleic Acids Res 1980; 8: 1913—1931.

11. Taniguchi T., Ohno S., Fujii-Kuriyama Y. et al. The nucleotide sequence of human fibroblast interferon cDNA. Gene; 1980: 10: 11—15.

12. Biron C. A., Sen G. C. Interferons and other cytokines, p. 321—351 // In D. M. Knipe, P. M. Howley, D. E. Griffin, M. Martin, B. Roizman and S. E. Straus (ed.) Fields virology. 2001. 4th ed. Lippincott-Raven; Philadelphia, Pa.

13. Pestka S. The Interferons: 50 years after their discovery, there is much more to learn. Journ of Biol Chem 2007; 282: 28: 20047—20051.

14. Foster G. R., Germain C., JonesM. et al. Human T cells elicit IFN-alpha secretion from dendritic cells following cell to cell interactions. Eur J Immunol 2000; 30: 3228—3235.

15. Bach E. A., Agreet M., Schreiber R. D. The IFN gamma receptor: a paradigm for cytokine receptor signalling. Annu Rev Immunol 1997; 15: 563—591.

16. Malmgaard L. Induction and regulation of IFNs during viral infection. J Interferon and Cytokine Res 2004; 24: 8: 439—454.

17. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783—801.

18. Matsumoto M., Funami K., Tanabe M. et al. Subcellular localization of toll-like receptor 3 in human dendritic cells. J Immunol 2003; 171: 3154—3162.

19. Choe J., Kelker M. S., Wilson I. A. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 2005; 309: 581—585.

20. Yamamoto M., Sato S., Hemmi H. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signalling pathway. Science 2003; 301; 640—643.

21. Hoebe K., Du X., Georgel P. et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003; 424; 743—748.

22. Hemmi H., Takeuchi O., Sato S. et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharides and double stranded RNA signalling and viral infection. J Exp Med 2004; 199: 1641—1650.

23. Perry A. K., Chow E. K., Goodnough J. B. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med 2004; 199: 1651—1658.

24. Uematsu S., Akira S. Toll-like receptors and type I interferons. J of Biol Chem 2006; 282: 21: 15319—15323.

25. Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1—14.

26. Honda K., Taniguchi T. IRFs: master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006; 6: 644—658.

27. Kurt-Jones E. A., Popova L., Kwinn L. et al. Pattern-recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000; 1: 398—401.

28. Rassa J. C., Meyers J. L., Zhang Y. et al. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA 2002; 99: 2281—2286.

29. McGettrick A. F., Brint E. K., Palsson-McDermott E. M. et al. Trif-related adapter molecule is phosphorylated by PKCe during toll-like receptor 4 signalling. Ibid 2006; 103: 9196—9201.

30. Compton T., Kurt-Jones E.A., Boehme K. W. et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2. J of Virol 2003; 77: 8: 4588—4596.

31. Kurt-Jones E. A., Chan M., Zhou S. et al. Herpes simplex virus 1 interaction with toll-like receptor 2 contributes to lethal encephalitis. PNAS 2004; 101: 5: 1315—1320.

32. Meylan E., Tschopp J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Molecular Cell 2006; 22: 561—569.

33. Pestka S., Langer J. A. , Zoon K. C., Samuel C. E. Interferons and their actions. Ann Rev Biochem 1987; 56: 317—332.

34. Samuel C. E. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 1991; 183: 1—11.

35. Stark G. R., Kerr J.M., Williams B. R. et al. How cells respond to interferons. Ann Rev Biochem 1998; 67: 227—264.

36. Knipe D. M., Samuel C. E., Palese P. Virus-host cell interactions, p. 133—170 // In D. M. Knipe, P. M. Howley, D. E. Griffin, M. Martin, B. Roizman and S. E. Straus (ed.) Fields virology, 2001. 4th ed. Lippincott-Raven; Philadelphia, Pa.

37. Samuel C. E. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14: 4: 778—809.

38. Mogensen K. E., Lewerenz M., Reboul J. et al. The type I interferon receptor: structure, function and evolution of a family business. J Interferon Cytokine Res 1999; 19: 1069—1098.

39. Deweerd N. A., Shamith A., Samarajiwa, P. J. Hertzog. Type I interferon receptors: biochemistry and biological functions. J Biol Chem 2007; 282: 28: 20053—20057.

40. Heim M. H. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. J Receptor Signal Transduction Res 1999; 9: 75—120.

41. Shindler C., Levy D. E., Decker T. JAK-STAT signalling: from interferons to cytokines. J Biol Chem 2007; 282: 28: 20059—20063.

42. Ozato K., Tailor P., Kubota T. The interferons regulatory factor family in host defense: mechanism of action. Ibid; 20065—20069.

43. Platanias L. C. Mechanisms of type-I and type-II-interferon-mediated signalling. Nat Rev Immunol 2005; 5: 375—386.

44. Gil M. P., Bohn E., O'Guin A. K. et al. Biologic consequences of STAT-1-independent IFN-signalling. Proc Natl Acad Sci USA 2001; 98: 6680—6685.

45. Gil J., Alcami J., Esteban M. Induction of apoptosis by double-stranded RNA-dependent protein kinase PKR involves the a subunit of eucariotic translation initiation factor 2 and NF-kB. Mol Cell Biol 19: 4653—4663.

46. Barber G. N. Host defence, viruses and apoptosis. Cell Death Differ 2001; 8: 2: 113—126.

47. Le Bon A., Schiavoni G., D'Agostino G. et al. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001; 14: 461—70.

48. Biron C. A. Role of early cytokines, including a and β interferons (IFN a/β), in innate and adaptive immune responses to viral infections. Semin Immunol 1998; 5: 383—390.

49. Pien G. C., Nguyen B., Malmgaard L. et al. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J Immunol 2002; 169: 5827—5837.

50. Garcia-Sastre A., Biron C. A. Type 1 intreferons and the virus-host relationship: a lesson in detente. Science 2006; 312: 879—882.